V015-3451 Screening compound: (2E)-N-[(3-methylphenyl)methyl]-3-phenyl-N-[4-({[2-(pyridin-2-yl)ethyl]carbamoyl}methyl)phenyl]prop-2-enamide

V015-3451 Screening compound: (2E)-N-[(3-methylphenyl)methyl]-3-phenyl-N-[4-({[2-(pyridin-2-yl)ethyl]carbamoyl}methyl)phenyl]prop-2-enamide
V015-3451 Screening compound: (2E)-N-[(3-methylphenyl)methyl]-3-phenyl-N-[4-({[2-(pyridin-2-yl)ethyl]carbamoyl}methyl)phenyl]prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-3451
(2E)-N-[(3-methylphenyl)methyl]-3-phenyl-N-[4-({[2-(pyridin-2-yl)ethyl]carbamoyl}methyl)phenyl]prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-3451

Molecular Formula

C32H31N3O2 (C32 H31 N3 O2)

Compound Name

(2E)-N-[(3-methylphenyl)methyl]-3-phenyl-N-[4-({[2-(pyridin-2-yl)ethyl]carbamoyl}methyl)phenyl]prop-2-enamide

IUPAC name

(2E)-N-[(3-methylphenyl)methyl]-3-phenyl-N-[4-({[2-(pyridin-2-yl)ethyl]carbamoyl}methyl)phenyl]prop-2-enamide

SMILES

Cc1cccc(CN(C(/C=C/c2ccccc2)=O)c2ccc(CC(NCCc3ncccc3)=O)cc2)c1

InChI

InChI=1S/C32H31N3O2/c1-25-8-7-11-28(22-25)24-35(32(37)18-15-26-9-3-2-4-10-26)30-16-13-27(14-17-30)23-31(36)34-21-19-29-12-5-6-20-33-29/h2-18,20,22H,19,21,23-24H2,1H3,(H,34,36)

InChI Key

MHKLVYYONDCDCF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19903247

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

489.62

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.168

Distribution Coefficient, logD

5.163

Water Solubility, LogSw

-4.97

Polar Surface Area

48.647

Acid Dissociation Constant (pKa)

14.09

Base Dissociation Constant (pKb)

5.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.60

V015-3451 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Regenerative Medicine Focused Library (23016 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V015-3451 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-3451?
Check Price and Availability of V015-3451, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-3451 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-3451
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-3451
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-3451 available by request